Acceleron Pharma has signed a lease on a third facility in Cambridge, further expanding its laboratory and office space by an additional 19,700 SF. Headquartered in Cambridge, Acceleron is a privately held biopharmaceutical company focused on discovering, developing, manufacturing, and commercializing biotherapeutics that modulate the growth of bone, muscle, red blood cells, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases.
